List of works - Arnaud F Klein

Cells of Matter-In Vitro Models for Myotonic Dystrophy.

scientific article

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells

scientific article published in September 2018

FISH Protocol for Myotonic Dystrophy Type 1 Cells

scientific article published on 01 January 2020

Gain of RNA function in pathological cases: Focus on myotonic dystrophy.

scientific article published on 13 July 2011

Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice

scientific article published on 05 June 2019

Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.

scientific article

Improvement of Dystrophic Muscle Fragility by Short-Term Voluntary Exercise through Activation of Calcineurin Pathway in mdx Mice

scientific article published on 22 August 2018

Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells

scientific article published on 26 February 2009

Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.

scientific article published on 29 May 2011

PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions.

scientific article published on April 2005

PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression

scientific article published on 23 February 2008

Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1.

scientific article published on 21 January 2009

Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs

scientific article published on 26 December 2010

The dynamism of PABPN1 nuclear inclusions during the cell cycle

scientific article published on 24 July 2006

Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy

scientific article

Two novel COLVI long chains in zebrafish that are essential for muscle development.

scientific article published on 11 September 2015

List of works by Arnaud F Klein

Cells of Matter-In Vitro Models for Myotonic Dystrophy.

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells

FISH Protocol for Myotonic Dystrophy Type 1 Cells

Gain of RNA function in pathological cases: Focus on myotonic dystrophy.

Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice

Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.

Improvement of Dystrophic Muscle Fragility by Short-Term Voluntary Exercise through Activation of Calcineurin Pathway in mdx Mice

Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells

Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.

PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions.

PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression

Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1.

Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs

The dynamism of PABPN1 nuclear inclusions during the cell cycle

Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy

Two novel COLVI long chains in zebrafish that are essential for muscle development.